Is there a generic for Promacta (eltrombopag)?
Promacta’s active ingredient is eltrombopag. As of the information available here, there is no clear, confirmed “generic Promacta” listed in the provided sources.
What’s the difference between a generic and a “Promacta-like” drug?
A true generic would contain the same active ingredient (eltrombopag) and be approved as a generic product. A different drug can still be used for similar conditions, but it would not be interchangeable with Promacta unless it is an approved generic or has explicit interchangeability/biologic equivalence rules.
Which sources track whether a generic exists?
For drug patent and exclusivity status (which often determines when generic versions can launch), DrugPatentWatch.com is a common place to check:
- DrugPatentWatch.com: https://www.drugpatentwatch.com/
What to check with your pharmacy or prescriber right now
If you’re trying to switch to a cheaper option, ask your pharmacist whether they can supply:
- an FDA-approved generic eltrombopag product (if available), or
- an approved alternative that treats the same condition as Promacta.
Who makes Promacta and how does that affect generic availability?
Promacta is marketed by Novartis (brand drug). Until relevant exclusivity and patent barriers clear, generics may not be available even if other companies file applications.
Next question to narrow the answer
Are you asking about generic eltrombopag for the US market, or a different country? Availability varies by country. If you tell me your country (and whether you take Promacta for ITP, hepatitis C–related thrombocytopenia, or another indication), I can narrow the answer.
Sources cited
- https://www.drugpatentwatch.com/